Reports Q4 revenue $43.8M, consensus $43.3M. "Based on the strong results we are reporting today and the continued momentum in our business, 2023 will be a groundbreaking year on our road to $500 million by 2026," said Juan Jose Chacon-Quiros, CEO. "This conviction is reflected in our 2023 revenue guidance of $200 million to $210 million. Preparations for commercial sales of Mia Femtech are progressing and approval in China is also expected in the first half of 2023, gaining us entry into the second largest global market. And in a major milestone for Establishment Labs, we have submitted module four of our modular PMA to the U.S. FDA, bringing us closer to approval of Motiva in the United States."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ESTA:
